Mistry described Scp776 as a “designer drug.” She explained that IGF-1 receptors are abundant throughout the body, and IGF-1 ...
Patients with chemorefractory metastatic colorectal cancer derive no overall survival benefit from giving anti-EGFR ...
Single-fraction SBRT did not significantly improve bone pain compared to conventional RT. Complete response rates were 37% with SBRT versus 25% with 3D conformal RT at 1 month and remained ...
A real-world study confirms the safety and efficacy of sofosbuvir-based therapies for treating hepatitis C in children aged 5 ...
For decades, poor treatment options and low-quality evidence plagued care for patients with rifampin-resistant tuberculosis. The advent of new drugs to treat tuberculosis and enhanced funding now ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback